Skip to main content
Top
Published in: BMC Cancer 1/2015

Open Access 01-12-2015 | Research article

The impact of supplementary narrative-based information on colorectal cancer screening beliefs and intention

Authors: Lesley M McGregor, Christian von Wagner, Gemma Vart, Wing Chee Yuen, Rosalind Raine, Jane Wardle, Kathryn A Robb

Published in: BMC Cancer | Issue 1/2015

Login to get access

Abstract

Background

The potential benefits of colorectal cancer screening are limited by low uptake. This study tested whether providing narrative accounts of the colorectal cancer (CRC) screening experience positively affected beliefs about CRC screening and intention to be screened.

Methods

4125 adults aged 45-59.5 years, from three general practices in England, were randomised to be sent the standard information on CRC screening or the standard information plus a narrative-based leaflet describing CRC screening experiences. Both groups were asked to complete and return a questionnaire on beliefs about CRC screening after reading the study materials. Between-group differences on responses were assessed with t-tests. A mediation analysis then addressed the mediating role of CRC screening beliefs on the group and intention relationship.

Results

Relative to the standard information group (n = 590), the standard information plus narrative leaflet group (n = 631) showed higher perceived vulnerability to CRC, higher perceived test response efficacy, a stronger belief that the screening test would provide peace of mind and less disgust with the test procedure. There were no between group differences on perceived self-efficacy or the understanding that the screening test should be done in the absence of symptoms. Respondents who received the additional narrative leaflet reported significantly higher CRC screening intentions than respondents who received the standard information only. Controlling for the CRC screening beliefs reduced the effect of group on intention to non-significance.

Conclusions

An additional narrative leaflet had a positive impact on beliefs about CRC screening which led to stronger screening intentions.
Appendix
Available only for authorised users
Literature
2.
go back to reference Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.CrossRefPubMed Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.CrossRefPubMed
3.
go back to reference Diaz JA, Slomka T. State of the art review: colorectal cancer screening. Am J Lifestyle Med. 2012;6:196–203.CrossRefPubMed Diaz JA, Slomka T. State of the art review: colorectal cancer screening. Am J Lifestyle Med. 2012;6:196–203.CrossRefPubMed
5.
go back to reference Libby G, Brewster DH, McClements PL, Carey FA, Black RJ, Birrell J, et al. The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study. Br J Cancer. 2012;107:255–9.CrossRefPubMedPubMedCentral Libby G, Brewster DH, McClements PL, Carey FA, Black RJ, Birrell J, et al. The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study. Br J Cancer. 2012;107:255–9.CrossRefPubMedPubMedCentral
6.
go back to reference Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut. 2012;61:1036–40.CrossRefPubMed Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut. 2012;61:1036–40.CrossRefPubMed
7.
go back to reference Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst. 2004;96:770–80.CrossRefPubMed Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst. 2004;96:770–80.CrossRefPubMed
8.
go back to reference Libby G, Bray J, Champion J, Brownlee LA, Birrell J, Gorman DR, et al. Pre-notification increases uptake of colorectal cancer screening in all demographic groups: a randomised controlled trial. J Med Screen. 2011;18:24–9.CrossRefPubMed Libby G, Bray J, Champion J, Brownlee LA, Birrell J, Gorman DR, et al. Pre-notification increases uptake of colorectal cancer screening in all demographic groups: a randomised controlled trial. J Med Screen. 2011;18:24–9.CrossRefPubMed
9.
go back to reference Tseng DS, Cox E, Plane MB, Hla KM. Efficacy of patient letter reminders on cervical cancer screening: a meta analysis. J Gen Intern Med. 2001;16:563–8.CrossRefPubMedPubMedCentral Tseng DS, Cox E, Plane MB, Hla KM. Efficacy of patient letter reminders on cervical cancer screening: a meta analysis. J Gen Intern Med. 2001;16:563–8.CrossRefPubMedPubMedCentral
10.
go back to reference Wagner TH. The effectiveness of mailed patient reminders on mammography screening: A meta-analysis. Am J Prev Med. 1998;14:64–70.CrossRefPubMed Wagner TH. The effectiveness of mailed patient reminders on mammography screening: A meta-analysis. Am J Prev Med. 1998;14:64–70.CrossRefPubMed
11.
go back to reference von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol. 2011;40:712–8.CrossRef von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol. 2011;40:712–8.CrossRef
12.
go back to reference Power E, Van Jaarsveld CH, McCaffery K, Miles A, Atkin W, Wardle J. Understanding intentions and action in colorectal cancer screening. Ann Behav Med. 2008;35:285–94.CrossRefPubMed Power E, Van Jaarsveld CH, McCaffery K, Miles A, Atkin W, Wardle J. Understanding intentions and action in colorectal cancer screening. Ann Behav Med. 2008;35:285–94.CrossRefPubMed
13.
go back to reference Witte K. Putting the fear back into fear appeals: The extended parallel process model. Commun Monogr. 1992;59:329–49.CrossRef Witte K. Putting the fear back into fear appeals: The extended parallel process model. Commun Monogr. 1992;59:329–49.CrossRef
14.
go back to reference Chapple A, Ziebland S, Hewitson P, McPherson A. What affects the uptake of screening for bowel cacner using faecal occult blood test (FOBt): a qualitative study. Soc Sci Med. 2008;66:2425–35.CrossRefPubMed Chapple A, Ziebland S, Hewitson P, McPherson A. What affects the uptake of screening for bowel cacner using faecal occult blood test (FOBt): a qualitative study. Soc Sci Med. 2008;66:2425–35.CrossRefPubMed
15.
go back to reference Jones RM, Devers KJ, Kuzel AJ, Woolf SH. Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am J Prev Med. 2010;38:508–16.CrossRefPubMedPubMedCentral Jones RM, Devers KJ, Kuzel AJ, Woolf SH. Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am J Prev Med. 2010;38:508–16.CrossRefPubMedPubMedCentral
16.
go back to reference van Dam L, Korfage IJ, Kuipers EJ, Hol L, van Roon AHC, Reijerink JCIY, et al. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy? Eur J Cancer. 2013;49:2321–30.CrossRefPubMed van Dam L, Korfage IJ, Kuipers EJ, Hol L, van Roon AHC, Reijerink JCIY, et al. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy? Eur J Cancer. 2013;49:2321–30.CrossRefPubMed
17.
go back to reference Palmer CK, Thomas MC, von Wagner C, Raine R. Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study. Br J Cancer. 2014;110:1705–11.CrossRefPubMedPubMedCentral Palmer CK, Thomas MC, von Wagner C, Raine R. Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study. Br J Cancer. 2014;110:1705–11.CrossRefPubMedPubMedCentral
18.
go back to reference Robb KA, Solarin I, Power E, Atkin W, Wardle J. Attitudes to colorectal cancer screening among ethnic minority groups in the UK. BMC Public Health. 2008;8:34.CrossRefPubMedPubMedCentral Robb KA, Solarin I, Power E, Atkin W, Wardle J. Attitudes to colorectal cancer screening among ethnic minority groups in the UK. BMC Public Health. 2008;8:34.CrossRefPubMedPubMedCentral
19.
go back to reference Kim HS, Bigman CA, Leader AE, Lerman C, Cappella JN. Narrative health communication and behavior change: the influence of exemplars in the news on intention to quit smoking. J Commun. 2012;62:473–92.CrossRefPubMedPubMedCentral Kim HS, Bigman CA, Leader AE, Lerman C, Cappella JN. Narrative health communication and behavior change: the influence of exemplars in the news on intention to quit smoking. J Commun. 2012;62:473–92.CrossRefPubMedPubMedCentral
20.
go back to reference Green MC. Narratives and cancer communication. J Commun. 2006;56:S163–83.CrossRef Green MC. Narratives and cancer communication. J Commun. 2006;56:S163–83.CrossRef
21.
go back to reference Kreuter MW, Green M, Cappella J, Slater M, Wise M, Storey D, et al. Narrative communication in cancer prevention and control: A framework to guide research and application. Ann Behav Med. 2007;33:221–35.CrossRefPubMed Kreuter MW, Green M, Cappella J, Slater M, Wise M, Storey D, et al. Narrative communication in cancer prevention and control: A framework to guide research and application. Ann Behav Med. 2007;33:221–35.CrossRefPubMed
22.
go back to reference Miller-Day M, Hecht ML. Narrative means to preventative ends: a narrative engagement framework for designing prevention interventions. Health Commun. 2013;28:657–70.CrossRefPubMedPubMedCentral Miller-Day M, Hecht ML. Narrative means to preventative ends: a narrative engagement framework for designing prevention interventions. Health Commun. 2013;28:657–70.CrossRefPubMedPubMedCentral
23.
go back to reference Kreuter MW, Holmes K, Alcaraz K, Kalesan B, Rath S, Richert M, et al. Comparing narrative and informational videos to increase mammography in low-income African American women. Patient Educ Couns. 2010;81:S6–14.CrossRefPubMedPubMedCentral Kreuter MW, Holmes K, Alcaraz K, Kalesan B, Rath S, Richert M, et al. Comparing narrative and informational videos to increase mammography in low-income African American women. Patient Educ Couns. 2010;81:S6–14.CrossRefPubMedPubMedCentral
24.
go back to reference Dillard AJ, Fagerlin A, Cin SD, Zikmund-Fisher BJ, Ubel PA. Narratives that address affective forecasting errors reduce perceived barriers to colorectal cancer screening. Soc Sci Med. 2010;71:45–52.CrossRefPubMedPubMedCentral Dillard AJ, Fagerlin A, Cin SD, Zikmund-Fisher BJ, Ubel PA. Narratives that address affective forecasting errors reduce perceived barriers to colorectal cancer screening. Soc Sci Med. 2010;71:45–52.CrossRefPubMedPubMedCentral
25.
go back to reference Jensen JD, King AJ, Carcioppolo N, Krakow M, Samadder NJ, Morgan S. Comparing tailored and narrative worksite interventions at increasing colonoscopy adherence in adults 50-75: a randomized controlled trial. Soc Sci Med. 2014;104:31–40.CrossRefPubMed Jensen JD, King AJ, Carcioppolo N, Krakow M, Samadder NJ, Morgan S. Comparing tailored and narrative worksite interventions at increasing colonoscopy adherence in adults 50-75: a randomized controlled trial. Soc Sci Med. 2014;104:31–40.CrossRefPubMed
26.
go back to reference Wardle J, Williamson S, McCaffery K, Sutton S, Taylor T, Edwards R, et al. Increasing attendance at colorectal cancer screening: testing the efficacy of a mailed, psychoeducational intervention in a community sample of older adults. Health Psychol. 2003;22:99–105.CrossRefPubMed Wardle J, Williamson S, McCaffery K, Sutton S, Taylor T, Edwards R, et al. Increasing attendance at colorectal cancer screening: testing the efficacy of a mailed, psychoeducational intervention in a community sample of older adults. Health Psychol. 2003;22:99–105.CrossRefPubMed
29.
go back to reference Shaffer VA, Zikmund-Fisher BJ. All stories are not alike: a purpose-, content-, and valence-based taxonomy of patient narratives in decision aids. Med Decis Making. 2012;33:4–13.CrossRefPubMed Shaffer VA, Zikmund-Fisher BJ. All stories are not alike: a purpose-, content-, and valence-based taxonomy of patient narratives in decision aids. Med Decis Making. 2012;33:4–13.CrossRefPubMed
30.
go back to reference Dillard AJ, Main JL. Using a health message with a testimonial to motivate colon cancer screening: associations with perceived identification and vividness. Health Educ Behav. 2013;40:673–82.CrossRefPubMed Dillard AJ, Main JL. Using a health message with a testimonial to motivate colon cancer screening: associations with perceived identification and vividness. Health Educ Behav. 2013;40:673–82.CrossRefPubMed
31.
go back to reference Helitzer D, Hollis C, Cotner J, Oestreicher N. Health literacy demands of written health information material: an assessment of cervical cancer prevention materials. Cancer Control. 2009;16(1):70–8.PubMed Helitzer D, Hollis C, Cotner J, Oestreicher N. Health literacy demands of written health information material: an assessment of cervical cancer prevention materials. Cancer Control. 2009;16(1):70–8.PubMed
32.
go back to reference Dillard AJ, Ferrer RA, Ubel PA, Fagerlin A. Risk perception measures’ association with behavior intentions, affect, and cognition following colon cancer screening messages. Health Psych. 2012;31:106–13.CrossRef Dillard AJ, Ferrer RA, Ubel PA, Fagerlin A. Risk perception measures’ association with behavior intentions, affect, and cognition following colon cancer screening messages. Health Psych. 2012;31:106–13.CrossRef
33.
go back to reference Rawl S, Champion V, Menon U, Loehrer PJ, Vance GH, Skinner CS. Validation of scales to measure benefits of and barriers to colorectal cancer screening. J Psychosoc Oncol. 2001;19:47–63.CrossRef Rawl S, Champion V, Menon U, Loehrer PJ, Vance GH, Skinner CS. Validation of scales to measure benefits of and barriers to colorectal cancer screening. J Psychosoc Oncol. 2001;19:47–63.CrossRef
34.
go back to reference Wardle J, McCaffery K, Nadel M, Atkin W. Socioeconomic differences in cancer screening participation: comparing cognitive and psychosocial explanations. Soc Sci Med. 2004;59:249–61.CrossRefPubMed Wardle J, McCaffery K, Nadel M, Atkin W. Socioeconomic differences in cancer screening participation: comparing cognitive and psychosocial explanations. Soc Sci Med. 2004;59:249–61.CrossRefPubMed
35.
go back to reference Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Meth Ins C. 2004;36:717–31.CrossRef Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Meth Ins C. 2004;36:717–31.CrossRef
36.
go back to reference Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008;40:879–91.CrossRefPubMed Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008;40:879–91.CrossRefPubMed
37.
go back to reference Rosenstock IM. Why people use health services. Milbank Meml Fund Q. 1966;44:94–124.CrossRef Rosenstock IM. Why people use health services. Milbank Meml Fund Q. 1966;44:94–124.CrossRef
38.
go back to reference Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84:191–215.CrossRefPubMed Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84:191–215.CrossRefPubMed
39.
go back to reference Hewitson P, Ward AM, Heneghan C, Halloran SP, Mant D. Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial. Brit J Cancer. 2011;105:475–80.CrossRefPubMedPubMedCentral Hewitson P, Ward AM, Heneghan C, Halloran SP, Mant D. Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial. Brit J Cancer. 2011;105:475–80.CrossRefPubMedPubMedCentral
40.
go back to reference Reeder AI. “It’s a small price to pay for life”: faecal occult blood test (FOBT) screening for colorectal cancer, perceived barriers and facilitators. The New Zeal Med J. 2011;124:11–7.PubMed Reeder AI. “It’s a small price to pay for life”: faecal occult blood test (FOBT) screening for colorectal cancer, perceived barriers and facilitators. The New Zeal Med J. 2011;124:11–7.PubMed
Metadata
Title
The impact of supplementary narrative-based information on colorectal cancer screening beliefs and intention
Authors
Lesley M McGregor
Christian von Wagner
Gemma Vart
Wing Chee Yuen
Rosalind Raine
Jane Wardle
Kathryn A Robb
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2015
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-015-1167-3

Other articles of this Issue 1/2015

BMC Cancer 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine